Search Results - "Oh, Jung M."

Refine Results
  1. 1

    Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus by Lee, Joo H., Yang, Si H., Oh, Jung M., Lee, Myung G.

    Published in Journal of pharmacy and pharmacology (01-01-2010)
    “…Objectives In rats with diabetes mellitus induced by alloxan (DMIA) or streptozocin (DMIS), changes in the cytochrome P450 (CYP) isozymes in the liver, lung,…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats by Choi, Young H., Bae, Soo K., Oh, Jung M., Kim, Sun-Ok, Lee, Myung G.

    Published in Biopharmaceutics & drug disposition (01-10-2007)
    “…It has been reported that the plasma (or serum) levels of albumin and globulins were lower and higher, respectively, than the serum levels in control rats…”
    Get full text
    Journal Article
  3. 3

    search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion by Jung, Chang H, Yang, Yoo-Soo, Kim, Jun-Seob, Shin, Jae-Il, Jin, Yong-Su, Shin, Jae Y, Lee, Jong H, Chung, Koo M, Hwang, Jae S, Oh, Jung M, Shin, Yeon-Kyun, Kweon, Dae-Hyuk

    Published in The FEBS journal (01-06-2008)
    “…Soluble N-ethylmaleimide sensitive-factor attachment receptor (SNARE) proteins have crucial roles in driving exocytic membrane fusion. Molecular recognition…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Comparison of Azathioprine and Mycophenolate Mofetil for the Prevention of Acute Rejection in Recipients of Pancreas Transplantation by Oh, Jung M., Wiland, Anne M., Klassen, David K., Weidle, Paul J., Bartlett, Stephen T.

    Published in Journal of clinical pharmacology (01-08-2001)
    “…The study was performed to compare the efficacy and side effects of azathioprine (AZA) and mycophenolate mofetil (MMF) in conjunction with cyclosporine or…”
    Get full text
    Journal Article
  7. 7

    P-125: Modeling of the Performance of Electrowetting Displays by Vermeulen, Paul, Feenstra, Johan, Giraldo, Andrea, Hampton, Mathieu W., Oh, Jung M., Mugele, Frieder

    “…This paper shows the results of modeling work to determine the effect of variations in the electrowetting display manufacturing process on the front‐of‐screen…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity by Kimchi-Sarfaty, Chava, Oh, Jung Mi, Kim, In-Wha, Sauna, Zuben E., Calcagno, Anna Maria, Ambudkar, Suresh V., Gottesman, Michael M.

    “…Synonymous single-nucleotide polymorphisms (SNPs) do not produce altered coding sequences, and therefore they are not expected to change the function of the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    T-shaped Angioplasty with Apex Puncture of Thrombosed Looped Hemodialysis Grafts by Suk Oh, Jung, MD, Gil Choi, Byung, MD, PhD, Jong Chun, Ho, MD, PhD, Giu Lee, Hae, MD, PhD

    “…Abstract This study is a retrospective evaluation of an alternative technique for angioplasty of thrombosed loop hemodialysis grafts through a single vascular…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients by Kim, Kyung Im, Huh, Ik-Soo, Kim, In-Wha, Park, Taesung, Ahn, Kwang-Sung, Yoon, Sung-Soo, Yoon, Jeong-Hyun, Oh, Jung Mi

    Published in European journal of cancer (1990) (01-01-2013)
    “…Abstract Cytarabine arabinoside (ara-C) is the key agent for treating acute myeloid leukaemia (AML). Here, we genotyped 139 single nucleotide polymorphisms…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation by Kim, In-Wha, Yun, Hwi-yeol, Choi, Boyoon, Han, Nayoung, Kim, Myeong Gyu, Park, Seonyang, Oh, Jung Mi

    Published in European journal of clinical pharmacology (01-08-2013)
    “…Purpose To build a population pharmacokinetic (PK) model of cyclophosphamide (CY) and its metabolite, 4-hydroxycyclophosphamide (HCY), in patients undergoing…”
    Get full text
    Journal Article
  18. 18

    CYP3A5 1 Allele: Impacts on Early Acute Rejection and Graft Function in Tacrolimus-Based Renal Transplant Recipients by MIN, Sang-Il, SEONG YUP KIM, SANG HYUN AHN, MIN, Seung-Kee, SI HWA KIM, YON SU KIM, KYUNG CHUL MOON, JUNG MI OH, SANG JOON KIM, HA, Jongwon

    Published in Transplantation (27-12-2010)
    “…Tacrolimus is a major immunosuppressant, which has a narrow therapeutic range and wide interindividual variation. The effects of genetic polymorphisms of…”
    Get full text
    Conference Proceeding Journal Article
  19. 19

    Can mean platelet volume predict the prognosis of patients with acute kidney injury requiring continuous renal replacement therapy? Response to comments by Park, Kyoung Sook, MD, Oh, Hyung Jung, MD

    Published in Journal of critical care (01-02-2015)
    “…[...]we tried to show whether MPV has an additional significant prognostic effect on the 28-day all-cause mortality in the patients with AKI treated with CRRT,…”
    Get full text
    Journal Article
  20. 20

    Identification of Factors Affecting Tacrolimus Level and 5-Year Clinical Outcome in Kidney Transplant Patients by Kim, In-Wha, Noh, Hyejin, Ji, Eunhee, Han, Nayoung, Hong, Su Hyun, Ha, Jongwon, Burckart, Gilbert J., Oh, Jung Mi

    Published in Basic & clinical pharmacology & toxicology (01-10-2012)
    “…The purpose of this study was to identify and characterize the association of various clinical variables and CYP3A5 genotypes with the pharmacokinetics of…”
    Get full text
    Journal Article